Clinical Trial

Lungs on Fire: Wildfire Smoke, Incident Diseases, Susceptible Populations, and Community Values in Canada

Study acronym: LoF
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Wildfire smoke (WFS) is the leading climate-related risk in Canada and the main source of harmful air pollution. While short-term breathing problems caused by smoke are well known, there is limited knowledge on how repeated exposure contributes to long-term lung disease. This study is a controlled human exposure to varying concentrations of WFS in a safe setting. By comparing the effects of different concentrations, this research will improve understanding of health impacts, identify who may be most vulnerable to exposures, and explore biological changes that could lead to chronic illness.
Trial Details
NCT Number NCT07536178
Lead Sponsor University of British Columbia
Conditions Asthma, Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer
Enrollment 24 participants
Start Date 2026-04-01
Primary Completion 2029-08-31 (estimated)
Study Completion 2030-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-17